1238509

Hikma Pharmaceuticals USA INC — FEI 1510690

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 17, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Columbus, OH (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)